Literature DB >> 4181511

'Nuclear' antigens and antinuclear antibodies in mink sera.

E V Barnett, R C Williams, A J Kenyon, J E Henson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4181511      PMCID： PMC1409585     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  27 in total

1.  Studies on antinuclear antibodies.

Authors:  M Seligmann; A Cannat; M Hamard
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

2.  Aleutian disease gammopathy of mink induced with an ultra-filtrable agent.

Authors:  L Buko; A J Kenyon
Journal:  Nature       Date:  1967-10-07       Impact factor: 49.962

3.  Viral plasmacytosis (Aleutian disease) in mink. VI. The development of positive Coombs test in experimental infections.

Authors:  R Saison; L Karstad; T J Pridham
Journal:  Can J Comp Med Vet Sci       Date:  1966-06

Review 4.  The possible role of microorganisms and viruses in the etiology of chronic degenerative diseases of man.

Authors:  F R Abinanti
Journal:  Annu Rev Microbiol       Date:  1967       Impact factor: 15.500

5.  Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.

Authors:  E M Tan; P H Schur; R I Carr; H G Kunkel
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

6.  Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.

Authors:  E M Tan; H G Kunkel
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

7.  Isolation of serum fractions capable of producing Aleutian disease in mink.

Authors:  J B Henson; R C Williams; J R Gorham
Journal:  J Immunol       Date:  1966-09       Impact factor: 5.422

8.  Antinuclear antibodies in rabbit antisera.

Authors:  E V Barnett; J H Vaughan
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307

9.  Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis.

Authors:  C Krishnan; M H Kaplan
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

10.  Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy.

Authors:  R C Mellors; C Y Huang
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307
View more
  8 in total

1.  Aleutian disease--an example of slowly-progressive infectious disease.

Authors:  L Karstad
Journal:  Can Vet J       Date:  1970-02       Impact factor: 1.008

2.  Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus.

Authors:  S Alexandersen; M E Bloom; J Wolfinbarger
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

3.  Deposition of IgA in renal glomeruli of mink affected with Aleutian disease.

Authors:  J L Portis; J E Coe
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

4.  Pathogenesis of aleutian disease of mink: nature of the antiglobulin reaction and elution of antibody from erythrocytes and glomeruli of infected mink.

Authors:  H J Cho; D G Ingram
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

5.  A DNA-binding protein in the serum of certain mammalian species.

Authors:  R Thoburn; A I Hurvitz; H G Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

6.  Autoimmunity in Aleutian disease: contribution of antiviral and anti-DNA antibody to hypergammaglobulinemia.

Authors:  E C Hahn; P S Hahn
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

7.  Natural antibodies in sera of mink before and after the development of aleutian disease (viral plasmacytosis).

Authors:  H Tabel; D G Ingram; S M Fletch
Journal:  Can J Comp Med       Date:  1970-10

8.  Expression of Aleutian mink disease antigen in cell culture.

Authors:  E C Hahn; L Ramos; A J Kenyon
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.